IMMUPHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.39 GBX | -2.25% |
|
+13.27% | +43.37% |
| 06-05 | EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows | AN |
| 06-05 | ImmuPharma plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.73M | - | - | - | - | - | |
| 59.28B | - | |||||
| 40.94B | ||||||
| 40.17B | ||||||
| 28.69B | ||||||
| 26.63B |
- Stock Market
- Equities
- IMM Stock
- Charts ImmuPharma plc
- Sector Chart
